FORM 8.3 - AON PLC

FORM 8.3 - AON PLC

BARCLAYS PLC

 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 10 February 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

423,622

0.19%

2,313,988

1.01%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

569,534

0.25%

30,257

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

23,000

0.01%

23,000

0.01%

 

 

 

 

(4)

TOTAL:

 

 

 

 

1,016,156

0.44%

2,367,245

1.04%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

2

226.7675 USD
Purchase

38

226.8921 USD
Purchase

68

227.3925 USD
Purchase

86

228.0000 USD
Purchase

100

228.0600 USD
Purchase

100

227.2800 USD
Purchase

100

226.3800 USD
Purchase

100

228.1050 USD
Purchase

145

229.8700 USD
Purchase

262

227.4712 USD
Purchase

300

227.4566 USD
Purchase

300

226.8200 USD
Purchase

306

226.5890 USD
Purchase

345

226.5243 USD
Purchase

400

226.4000 USD
Purchase

500

227.0379 USD
Purchase

600

226.5383 USD
Purchase

1,033

226.5347 USD
Purchase

1,100

226.5372 USD
Purchase

1,185

227.1751 USD
Purchase

1,300

228.0015 USD
Purchase

1,600

227.2750 USD
Purchase

1,964

227.3975 USD
Purchase

2,151

226.8096 USD
Purchase

2,786

227.9829 USD
Purchase

3,645

228.0058 USD
Purchase

3,700

227.9133 USD
Purchase

3,700

228.1274 USD
Purchase

3,704

227.7957 USD
Purchase

4,360

227.3456 USD
Purchase

4,508

227.7371 USD
Purchase

4,526

226.9726 USD
Purchase

4,571

227.9854 USD
Purchase

5,246

227.8833 USD
Purchase

5,801

227.9104 USD
Purchase

5,890

226.5500 USD
Purchase

6,224

227.8526 USD
Purchase

7,140

227.7591 USD
Purchase

7,304

227.8665 USD
Purchase

7,765

227.8695 USD
Purchase

9,186

227.0063 USD
Purchase

9,568

227.2166 USD
Purchase

19,559

226.7385 USD
Purchase

19,853

226.6054 USD
Purchase

23,820

227.9755 USD
Sale

2

226.7675 USD
Sale

38

226.8921 USD
Sale

100

226.4900 USD
Sale

100

227.8500 USD
Sale

100

227.1100 USD
Sale

100

227.5000 USD
Sale

100

227.8800 USD
Sale

145

229.8700 USD
Sale

200

228.3500 USD
Sale

200

226.4500 USD
Sale

312

227.2443 USD
Sale

346

227.7102 USD
Sale

440

226.8926 USD
Sale

671

228.2482 USD
Sale

763

226.5584 USD
Sale

860

227.3667 USD
Sale

1,051

226.5300 USD
Sale

1,184

226.5462 USD
Sale

1,977

228.1794 USD
Sale

2,805

226.5464 USD
Sale

2,871

227.2554 USD
Sale

3,052

228.1609 USD
Sale

4,400

228.2674 USD
Sale

5,594

227.4663 USD
Sale

5,793

226.5500 USD
Sale

7,565

227.9070 USD
Sale

15,663

227.9822 USD
Sale

24,078

226.9509 USD
Sale

40,000

226.7452 USD
Sale

59,271

227.7915 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

11 Feb 2021

Contact name: Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date

 

to which the option

 

 

 

 

or derivative

 

 

 

 

relates

 

 

 

Call Options

Purchased

23,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-23,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings